Medication Monitor

All Items



Generic Name (Trade Name—Company)
Notes
February 17, 2012

Acetaminophen

(Infants’ Tylenol Oral Suspension 1 oz. Grape—McNeil Consumer Healthcare)
Flow restrictor problem can be avoided with education

Seven lots of Infants' Tylenol Oral Suspension 1 oz. Grape have been recalled by McNeil Consumer Healthcare at the wholesale and retail levels. The nationwide recall affects 574,000 bottles of the product.

McNeil said that it took this action "as a precaution after receiving a number of complaints from consumers" about difficulty with using the SimpleMeasure dosing system. In some bottles, the flow restrictor in the top of the bottle was pushed into the bottle when parents and caregivers inserted the dosing syringe.

Bottles of the products with intact flow restrictors can continue to be used, McNeil said. Pharmacists can help parents learn to use the SimpleMeasure system using an instructional video posted on YouTube. 

The company requests that consumers not use the product if the flow restrictor has been pushed into the bottle. Refunds can be requested at www.tylenol.com or by calling 888-222-6036 Monday through Friday, 8 a.m. to 8 p.m. Eastern time, and Saturday and Sunday, 9 a.m. to 5 p.m. Eastern time.

Lot numbers involved in the recall are BIL0U00, BIL0V00, BIL3500, BJL2D00, BJL2E00, BJL2T00, and BJL2U00.

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2011 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

More info

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.